scispace - formally typeset
L

Lubna Al-Khalili

Researcher at Karolinska Institutet

Publications -  24
Citations -  1642

Lubna Al-Khalili is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Skeletal muscle & Glucose uptake. The author has an hindex of 19, co-authored 24 publications receiving 1559 citations. Previous affiliations of Lubna Al-Khalili include Karolinska University Hospital & Royal Institute of Technology.

Papers
More filters
Journal ArticleDOI

Signaling Specificity of Interleukin-6 Action on Glucose and Lipid Metabolism in Skeletal Muscle

TL;DR: IL-6 increases glycogen synthesis via a PI3-kinase-dependent mechanism and enhances lipid oxidation via an AMPK- dependent mechanism in skeletal muscle.
Journal ArticleDOI

siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle

TL;DR: SiRNA was utilized to decipher the specific role of predominant insulin receptor substrates and Akt isoforms expressed in human skeletal muscle and revealed specialized roles of insulin signaling cascades to metabolic endpoints.
Journal ArticleDOI

Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle.

TL;DR: This study confirmed that incubation of primary cultured human muscle cells with GW501516 induced AMPK phosphorylation and increased fatty acid transport and oxidation and glucose uptake and demonstrated that PPARδ expression is required for the effect of GW 501516 on the intracellular accumulation of fatty acids.
Journal ArticleDOI

Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content.

TL;DR: It is demonstrated that insulin-stimulated glucose transport in cultured human skeletal muscle is mediated by GLUT4, as no effect on GLUT1 appearance at the plasma membrane was noted and cultured myotubes are a useful tool to facilitate biological and molecular validation of novel pharmacological agents aimed to improve glucose metabolism in skeletal muscle.
Journal ArticleDOI

Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta.

TL;DR: Evidence is provided to suggest that PPARdelta agonists increase glucose metabolism and promote gene regulatory responses in cultured human skeletal muscle and provide biological validation of PPardelta as a potential target for antidiabetic therapy.